Send to printer »

GEN News Highlights : Sep 19, 2006

Bentley Inks Deal with Cardinal Health

Bentley Pharmaceuticals secured capacity at Cardinal Health’s new North Raleigh, NC-based facility for the scaleup and manufacture of clinical supplies of Bentley’s intranasal insulin product candidate.

The product candidate utilizes Bentley’s CPE-215® drug delivery technology to deliver insulin directly through diabetic patients’ nasal mucosa using a nasal spray.